Renaissance Technologies - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$196
-40.1%
65,275
-50.8%
0.00%
Q2 2023$327
-53.8%
132,772
-57.6%
0.00%
-100.0%
Q1 2023$708
-6.8%
313,175
+43.8%
0.00%0.0%
Q4 2022$760
-99.8%
217,810
+1412.6%
0.00%
Q4 2021$324,000
-20.2%
14,400
-7.1%
0.00%
-100.0%
Q3 2021$406,00015,5000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders